-+ 0.00%
-+ 0.00%
-+ 0.00%

This Inspire Medical Systems Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Thursday

Benzinga·02/12/2026 14:21:46
Listen to the news

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

  • Baird analyst Mike Polark downgraded Inspire Medical Systems Inc (NYSE:INSP) from Outperform to Neutral and cut the price target from $130 to $74. Inspire Medical shares closed at $68.21 on Wednesday. See how other analysts view this stock.
  • JP Morgan analyst Jeffrey Zekauskas downgraded Valvoline Inc (NYSE:VVV) from Neutral to Underweight and raised the price target from $30 to $35. Valvoline shares closed at $38.87 on Wednesday. See how other analysts view this stock.
  • Wells Fargo analyst Eva Fortea Verdejo downgraded Arcus Biosciences Inc (NYSE:RCUS) from Overweight to Equal-Weight and slashed the price target from $30 to $23. Arcus Biosciences shares closed at $21.36 on Wednesday. See how other analysts view this stock.
  • Wells Fargo analyst Jason Haas downgraded Rollins Inc (NYSE:ROL) from Overweight to Equal-Weight and cut the price target from $68 to $56. Rollins shares closed at $65.60 on Wednesday. See how other analysts view this stock.

Considering buying INSP stock? Here’s what analysts think:

Photo via Shutterstock